04.06.2014 Views

here - United Kingdom Parliament

here - United Kingdom Parliament

here - United Kingdom Parliament

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

1747 Pollinators and Pesticides<br />

6 JUNE 2013 Pollinators and Pesticides 1748<br />

Let me move on to the question of why insect populations<br />

might be declining. I want to make it clear at the outset<br />

that the health of insect pollinators is defined by a<br />

range of factors, including not only pesticides but<br />

urbanisation, loss of habitat, agricultural intensification<br />

and climate change; obviously, weather patterns affect<br />

things as well.<br />

Dame Joan Ruddock (Lewisham, Deptford) (Lab):<br />

My hon. Friend will know that the Government intend<br />

to issue—shortly, I believe—planning guidance on<br />

biodiversity. Does she agree that councils need to be<br />

encouraged and given the impetus to protect and restore<br />

bee-friendly habitats in their own neighbourhoods, which<br />

would make a real contribution to addressing the point<br />

she is making?<br />

Joan Walley: I thank my right hon. Friend; she makes<br />

exactly the right point, and I absolutely agree. We need<br />

safe havens for wildlife, especially in urban areas, although<br />

it is not just about urban areas. The planning system<br />

underpins the whole issue of our natural capital and<br />

biodiversity. If we do not have guidance on how we<br />

protect and enhance our natural environment, the bees<br />

do not stand a chance.<br />

Throughout our inquiry, the Environmental Audit<br />

Committee acknowledged the importance of sustaining<br />

agricultural yields, controlling pests effectively and<br />

maintaining food security. Indeed, those concerns were<br />

reflected in our final report. Equally, we were mindful<br />

of the value of insect pollinators as an ecosystem<br />

service to UK agriculture. I think that Members will be<br />

aware of the various estimates of the agricultural value<br />

of insect pollination, ranging from £500 million to<br />

£1.9 billion, depending on whether one takes into account<br />

the cost of replacement hand pollination. We felt that<br />

those issues ought to be given a value and taken into<br />

account.<br />

In case anyone thinks that our report is just about a<br />

moratorium on certain neonicotinoids, I hope they will<br />

have a chance to read it in full and make themselves<br />

aware of the cross-cutting nature of our work and the<br />

importance that we give to using the common agricultural<br />

policy control to help British farming move as quickly<br />

as possible to integrated pest management.<br />

As I have said, the Committee considered a range of<br />

factors that affect insect pollinators, but we were driven<br />

to scrutinise the effects of one family of insecticides—<br />

neonicotinoids—by the weight of peer-reviewed scientific<br />

evidence. For Members who are not familiar with<br />

neonicotinoids, I should say that they are a class of<br />

insecticide derived from nicotine. Following their<br />

introduction in the mid-’90s, they have been widely used<br />

in the UK on oilseed rape, cereals, maize, sugar beet<br />

and crops grown in glass houses. The body of evidence<br />

indicating that neonicotinoids cause acute harm to bees<br />

grew appreciably in the course of our inquiry, as new<br />

studies were published in heavyweight journals such as<br />

Science and Nature. In this case, harm to bees includes<br />

increased susceptibility to disease and reduced foraging<br />

and reproduction. If Members are interested in the<br />

particular scientific studies, I refer them to the Henry,<br />

Whitehorn and Gill experiments.<br />

We heard that 94% of published peer-reviewed<br />

experiments on the effects of neonicotinoids on bees<br />

found evidence of acute harm. The Department for<br />

Environment, Food and Rural Affairs and the agri-chemical<br />

industry argued throughout our inquiry that the dosage<br />

used in those laboratory experiments was too high. In<br />

response it is worth pointing out that those studies used<br />

dosages derived from the best available data on the<br />

concentrations of neonicotinoids that bees encounter in<br />

the field.<br />

The agri-chemical industry also likes to cite its own<br />

tests as proof that neonicotinoids cannot harm bees.<br />

However, the industry studies by which neonicotinoids<br />

were licensed for use in the European Union were not<br />

peer reviewed and are not open to scrutiny due to the<br />

supposed commercial sensitivity of the data. Furthermore,<br />

we found evidence in relation to the licensing of<br />

imidacloprid which calls into question altogether the<br />

rigour of the testing regime.<br />

Against that background, we went on to consider the<br />

precautionary principle. By definition, insecticides kill<br />

insects. The precautionary question is whether neonicotinoid<br />

insecticides have an unsustainable impact on insect<br />

pollinators. The 1992 <strong>United</strong> Nations Rio declaration<br />

on environment and development states:<br />

“W<strong>here</strong> t<strong>here</strong> are threats of serious and irreversible damage,<br />

lack of full scientific certainty shall not be used as a reason for<br />

postponing cost-effective measures to prevent environmental<br />

degradation.”<br />

That internationally agreed definition of the precautionary<br />

principle was later enshrined in the Lisbon treaty and it<br />

underpins much of the work that has been done on<br />

sustainable development, including when the work of<br />

the Rio conference was built on at Rio+20 only last<br />

year in Brazil.<br />

Throughout our inquiry, DEFRA used what it identified<br />

as a lack of full scientific certainty as an excuse for<br />

inaction. For example, at one stage the Department<br />

stated that it would require unequivocal evidence of<br />

harm before acting on neonicotinoids.<br />

Dr Sarah Wollaston (Totnes) (Con): In medical research,<br />

t<strong>here</strong> is a huge issue with drug companies not publishing<br />

inconvenient data. Does the hon. Lady feel that that is a<br />

serious problem with neonicotinoids?<br />

Joan Walley: I am grateful to the hon. Lady for<br />

raising that point about commercial confidentiality and<br />

the lack of transparency. We hear a lot at the moment<br />

about lobbying and related issues, but if the agri-chemical<br />

industry wishes to make claims about the value of its<br />

products, it must open up the evidence to full scrutiny.<br />

T<strong>here</strong> is no case for hiding behind so-called “commercial<br />

confidentiality”. That prevents the open, transparent<br />

and informed policy making that is so badly needed. I<br />

agree with the hon. Lady and her point relates to one of<br />

the recommendations in our report.<br />

When the weight of peer-reviewed evidence rendered<br />

untenable DEFRA’s position on the need for unequivocal<br />

evidence, it claimed that it would commission the Food<br />

and Environment Research Agency to conduct a realistic<br />

field study to resolve the matter. That study was not<br />

peer reviewed and it was, as one witness to our inquiry<br />

presciently pointed out, clearly too small to provide<br />

conclusive results. It was undermined by fundamental<br />

errors in its execution, such as placing the various hives<br />

that were used in the experiments outside on different<br />

days of the year.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!